Onishi Hiraku, Machida Yoshiharu
Department of Drug Delivery Research, Hoshi University, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Molecules. 2008 Aug 10;13(9):2136-55. doi: 10.3390/molecules13092136.
Macromolecular prodrugs are very useful systems for achieving controlled drug release and drug targeting. In particular, various macromolecule-antitumor drug conjugates enhance the effectiveness and improve the toxic side effects. Also, polymeric micro- and nanoparticles have been actively examined and their in vivo behaviors elucidated, and it has been realized that their particle characteristics are very useful to control drug behavior. Recently, researches based on the combination of the concepts of macromolecular prodrugs and micro- or nanoparticles have been reported, although they are limited. Macromolecular prodrugs enable drugs to be released at a certain controlled release rate based on the features of the macromolecule-drug linkage. Micro- and nanoparticles can control in vivo behavior based on their size, surface charge and surface structure. These merits are expected for systems produced by the combination of each concept. In this review, several micro- or nanoparticles composed of macromolecule-drug conjugates are described for their preparation, in vitro properties and/or in vivo behavior.
大分子前药是实现药物控释和靶向给药的非常有用的体系。特别是,各种大分子-抗肿瘤药物偶联物提高了疗效并改善了毒副作用。此外,聚合物微纳米颗粒也得到了积极研究,其体内行为也得以阐明,并且人们已经认识到它们的颗粒特性对于控制药物行为非常有用。最近,尽管相关研究有限,但基于大分子前药与微纳米颗粒概念相结合的研究已有报道。大分子前药能够根据大分子-药物连接的特性以一定的控释速率释放药物。微纳米颗粒可以根据其大小、表面电荷和表面结构来控制体内行为。预计由每个概念组合产生的体系将具备这些优点。在本综述中,描述了几种由大分子-药物偶联物组成的微纳米颗粒的制备、体外性质和/或体内行为。